Shenzhen Neptunus Interlong Bio-technique Company Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 838.81 million compared to CNY 1,031.37 million a year ago. Net income was CNY 35.96 million compared to CNY 36.59 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0214 compared to CNY 0.0218 a year ago.